sunvozertinib
FDA Grants Accelerated Approval to Zegfrovy for Some Patients With Metastatic NSCLC
The FDA granted accelerated approval to sunvozertinib (Zegfrovy, Dizal [Jiangsu] Pharmaceutical) for adult patients ...
JULY 2, 2025

Load more